These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2657747)

  • 1. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hypophysectomy and the insulin-like and anti-insulin pituitary peptides on carbohydrate metabolism in yellow Avy/A (BALB/c x VY)F1 hybrid mice.
    Salem MA; Lewis UJ; Haro LS; Kishi K; McAllister DL; Seavey BK; Bee G; Wolff GL
    Proc Soc Exp Biol Med; 1989 Sep; 191(4):408-19. PubMed ID: 2672006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
    Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
    Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of glucose tolerance in yellow (Avy/A) (BALB/c X VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands.
    Frigeri LG; Wolff GL; Robel G
    Endocrinology; 1983 Dec; 113(6):2097-105. PubMed ID: 6357766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
    Salem MA
    Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
    Adamafio NA; Kostyo JL; Cameron CM; Trimark JR; Dunbar JC
    Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant-DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity.
    Lewis UJ; Lewis LJ; Salem MA; Staten NR; Galosy SS; Krivi GG
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):45-54. PubMed ID: 1936524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
    Towns R; Kostyo JL; Martin D; Chou SY; Bennink MR
    Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
    Adamafio NA; Cameron CM; Kostyo JL
    Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.
    Heffernan MA; Thorburn AW; Fam B; Summers R; Conway-Campbell B; Waters MJ; Ng FM
    Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1442-9. PubMed ID: 11673763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal peptide of growth hormone enhances insulin action in normal rats.
    Mondon CE; Reaven GM; Ling N; Lewis UJ; Frigeri LG
    Endocrinology; 1988 Aug; 123(2):827-33. PubMed ID: 3135175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.
    Kostyo JL; Cameron CM; Olson KC; Jones AJ; Pai RC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4250-3. PubMed ID: 3889926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age on responsiveness to diabetogenic action of growth hormone.
    Cameron CM; Kostyo JL
    Diabetes; 1987 Jan; 36(1):88-92. PubMed ID: 3539676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of cumulative body weight gain and adipose tissue mass in obese mice: response to chronic treatment with synthetic hGH 177-191 peptide.
    Natera SH; Jiang WJ; Ng FM
    Biochem Mol Biol Int; 1994 Aug; 33(5):1011-21. PubMed ID: 7987248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity.
    Mizuno TM; Bergen H; Funabashi T; Kleopoulos SP; Zhong YG; Bauman WA; Mobbs CV
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3434-8. PubMed ID: 8622953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).
    Lim N; Ng FM; Wu ZM; Ede N; Hearn MT
    Endocrinology; 1992 Aug; 131(2):835-40. PubMed ID: 1639027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Wyse BM; Gilchrist BJ
    Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hybrid noncovalent complex of fragments of porcine and human growth hormones with diabetogenic activity.
    Gennick SE; Kostyo JL; Mills JB; Eden S
    Endocrinology; 1983 Jun; 112(6):2069-75. PubMed ID: 6303758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.